United Therapeutics (UTHR -3%) slides after its Q1 EPS results missed Street expectations...

|About: United Therapeutics Corpora... (UTHR)|By:, SA News Editor

United Therapeutics (UTHR -3%) slides after its Q1 EPS results missed Street expectations earlier today. Revenue increased by nearly $41M over the prior year the period, with growth in product revenues reflecting the continuing increase in the number of patients being treated, but expenses in both R&D and SG&A pressured bottom line performance.